The Dr. V K Paul who is member of NITI Aayog has received a second dose of COVID 19 vaccine at All India Institute Of Medical Sciences (AIIMS) in New Delhi.
Mumbai : Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company has launched SUTIB, which is a generic version of Sunitinib oral capsules to treat kidney cancer in India. The drug SUTIB is launched at a MRP that is approx. 96% lower than the MRP priced at Rs. 7000 (50 mg), Rs. 3600 (25 mg) and Rs. 1840 (12.5 mg) per month.
Sunitinib is also approved by the US Food and Drug Administration (US FDA).
In the past decade, advances in research and drug development have begun to shift the paradigm of this Kidney cancer. Sunitinib is an oral multi-kinase inhibitor (MKI), works by blocking several enzymes that promote cell growth. It is useful for the treatment of certain patients with gastrointestinal stromal tumors and advanced renal cell carcinoma. It is also approved for patients with certain type of Pancreatic Neuroendocrine Tumours.
“Oncology is an important focus area for Glenmark. We recognize that advanced kidney cancer is a complex disease and patients in India are faced with limited treatment options. Glenmark is committed to bringing targeted and effective medicines at an affordable cost to physicians and their patients.” said Mr. Alok Malik, Vice President & Business Head, Glenmark India Formulation
The Union Ministry of Health has blocked the fake website demanding money for vaccination. The fake website claimed to provide #Covid-19 vaccine for Rs.4000- Rs.6000.
The #MOHFW has alerted people ‘not fall prey to such fraudulent websites.’ Union MoS HFW said, “The site ‘mohfw.xyz’ has been blocked. A case is registered and investigation taken up. Please be cautious. Do not fall prey to such fraudulent websites.”
The Press Information Bureau (PIB), “A website ‘mohfw.xyz’ is impersonating the official website of the Ministry of Health and Family Welfare and is claiming to offer #covid19vaccine for Rs. 4000 – Rs. 6000.” tweeted the twitter handle of Press Information Bureau (PIB) Fact Check which was the first one to bring the matter into light.
Apparently the Union Minister of Health and Family Welfare Dr. Harsh Vardhan has retweeted and appreciated @PIBFactCheck and @MoHFW_India for their swift response to bust a fake website.
“Appreciate @PIBFactCheck and @MoHFW_India for their swift response to bust a fake website collecting money on pretext of registration for #covid-19vaccination.” tweeted Dr. Harsh Vardhan
Dr. Harsh Vardhan further mentioned ,“urge people to exercise abundant precaution and verify accuracy of info on various channels of Govt Communication.”
Although, such matters have been in light even before the launch of the vaccine. The Ministry has since been alarming people of a fake app named Co-WIN which asked for the personal information of the individual for illegal use of the same.
UPDATE ON VACCINATIONS IN INDIA TILL NOW Total Vaccinations: 85,16,385 Vaccinations to HCWs: 61,54,894 Vaccinations to FLWs: 23,61,491.According to the Union Health Ministry 70% of Healthcare workers covered so far in 14 States/UT’s.
Total deaths reported till date: 28 (0.0003% of vaccinations)
Death in Hospital: 11
Death outside Hospital: 17
New Delhi – The Indian Medical Association (IMA) will continue to protest against the Centre’s order to train post-graduate practitioners in specified streams of Ayurveda , the IMA has called for a non-cooperation movement all over the country asking the surgeons and Anesthesiologists to not cooperate in training the Ayush doctors.
The Indian Medical Association(IMA) has also said that it will submit a list to the Union government of 1,000 modern medicine doctors for giving their services in remote areas of the country.
According to the Union Health Ministry , India’s recovery rate is the highest in the World . The recovery rate India is 97.31% .The patients who have been recovered so far are more then 1.06 crore people have recovered/discharged so far. The difference between recovered & active cases has grown to 1,04,74,164 today.
New Delhi – A 36 years old Inderpal while working in a factory in Prahaladpur Industrial Area, Badli, New Delhi , suddenly a heavy object from the machine fell on his hand and his left forearm got crushed and amputated. He suffered from severe pain , loss of blood and went into the shock. Immediately after the injury he was taken to the hospital for treatment that saved his amputated hand.
“Though the patient reached us well within the golden time period (usually 3 to 4 hours over ice in forearm level injury), it was challenging as the forearm at the time of amputation got badly pulled and crushed. This led to multiple level injuries to the various structures (bone, muscles, nerves and vessels), necessitating a holistic approach requiring extensive shortening and graft usage from different parts of the body.” said Dr. Anubhav Gupta, Senior Consultant, Department of Plastic and Reconstructive Surgery, Sir Ganga Ram Hospital
“The latest surgical techniques it is now possible to re-join even the worst amputated limbs if they are brought in time and well preserved in ice. It is important to understand that the amputated part should not be in direct contact of ice. It should be kept in a clean polythene over ice.” Dr. Anubhav Gupta further explained
Due to the severity of the injury, it took us over 6 hours to perform the implantation of the forearm using micro-vascular technique. By 12 midnight the patient was wheeled out form the operation theatre.
At present the patient’s hand has been successfully salvaged and he hopes to have a good hand functional recovery.
New Delhi – The second dose vaccination has been started today in India for the beneficiaries who have completed 28 days after receiving the first dose of the vaccine. According to the Union Health Ministry , total of 80,52,454 vaccinations have been carried out.
7,668 Healthcare workers received second dose today.
According to the report by Reuters, the University of Oxford has launched the study to assess the safety and immunogenicity of the COVID-19 vaccine in children for the first time from a vaccine developed by AstraZeneca.
The age group will be 6 and 17 to determine the effectiveness of vaccine.Around 300 volunteers will be inoculated this month.